Mobile app uses lights, camera to detect brain injury in real-time

Researchers from the University of Washington have begun development on a smartphone application that uses the camera to assess concussions and other brain injuries in real-time. Outlined in a paper set to be presented at Ubicomp 2017, the app hopes to provide an effective tool in protecting patients from further injury.

The PupilScreen app aims to fill the gap in tools that accurately detect the occurrence of a concussion or brain injury in real-time by examining a user's pupillary light reflex. The app uses the flash on the smartphone to stimulate the patient’s eyes while the camera records a three-second video. Deep learning algorithms then analyze changes in the pupil to assess the patient’s condition.

"Having an objective measure that a coach or parent or anyone on the sidelines of a game could use to screen for concussion would truly be a game-changer," said Shwetak Patel, the Washington Research Foundation Endowed Professor of Computer Science & Engineering and of Electrical Engineering at the University of Washington. "Right now, the best screening protocols we have are still subjective, and a player who really wants to get back on the field can find ways to game the system."

A pilot study on the app enrolled 48 participants, some with a traumatic brain injury and some healthy individuals. The app was capable of diagnosing brain injuries. Researchers hope the app will be available for launch in the next two years.

"PupilScreen aims to fill that gap by giving us the first capability to measure an objective biomarker of concussion in the field," said co-author Lynn McGrath, MD, a resident physician in UW Medicine's Department of Neurological Surgery. "After further testing, we think this device will empower everyone from little league coaches to NFL doctors to emergency department physicians to rapidly detect and triage head injury."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup